These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 417876)
1. [Cytotoxicity of mouse peritoneal cells after alloimmunization]. Debray-Sachs M; Dy M; Aurengo H; Descamps B C R Acad Hebd Seances Acad Sci D; 1978 Jan; 286(2):249-52. PubMed ID: 417876 [TBL] [Abstract][Full Text] [Related]
2. Macrophage cytotoxicity in the mouse immune response against a skin allograft. Dimitriu A; Dy M; Thomson N; Hamburger J J Immunol; 1975 Jan; 114(1 Pt 1):195-9. PubMed ID: 122985 [TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of peritoneal macrophages activated with Mycobacterium smegmatis. Yamamoto S; Tokunaga T Microbiol Immunol; 1978; 22(1):27-40. PubMed ID: 661626 [TBL] [Abstract][Full Text] [Related]
4. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target. Jiang H; Stewart CA; Fast DJ; Leu RW J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576 [TBL] [Abstract][Full Text] [Related]
5. Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes. Dullens HF; Schakenraad S; Oostdijk A; Vuist W; Van der Maas M; Den Otter W Cancer Immunol Immunother; 1986; 22(2):100-6. PubMed ID: 3487380 [TBL] [Abstract][Full Text] [Related]
6. Murine macrophage cytotoxicity induced by mastocytoma cells, cell-free mastocytoma exudates, and extracts. Dullens HF; Den Otter W Immunopharmacology; 1981 Sep; 3(3):241-51. PubMed ID: 6796544 [TBL] [Abstract][Full Text] [Related]
7. Effector cells of low-dose IL-2 immunotherapy in tumor bearing mice: tumor cell killing by CD8+ cytotoxic T lymphocytes and macrophages. Maas RA; Roest PA; Becker MJ; Weimar IS; Dullens HF; Den Otter W Immunobiology; 1992 Nov; 186(3-4):214-29. PubMed ID: 1490728 [TBL] [Abstract][Full Text] [Related]
8. Allograft cytotoxicity co-operation between alloimmune T cells and macrophages. Jones B; Jones TC Immunology; 1978 Feb; 34(2):247-55. PubMed ID: 414994 [TBL] [Abstract][Full Text] [Related]
9. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice. Dullens HF; Vuist W; Van der Maas M; Den Otter W Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093 [TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between in vivo peroxidatic activity patterns and tumoricidal activity in vitro of peritoneal macrophages after intraperitoneal immunization with tumor cells. Dullens HF; van Walraven R; Klomberg M; Rademakers LP; de Goey IC; den Otter W Immunobiology; 1988 Jul; 177(3):293-304. PubMed ID: 3169842 [TBL] [Abstract][Full Text] [Related]
11. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages. Sugawara I; Lee KC; Wong M Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974 [TBL] [Abstract][Full Text] [Related]
12. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro]. Viadro MM Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842 [TBL] [Abstract][Full Text] [Related]
13. Natural cell-mediated immunity to lymphoma cells. I. Characteristics of effector cells in a cytostasis assay in vitro. Tufveson G; Riesenfeld I; Rönnblom L; Hedman A; Alm GV J Natl Cancer Inst; 1977 Nov; 59(5):1491-7. PubMed ID: 302867 [TBL] [Abstract][Full Text] [Related]
15. Effect of cysteine ethylester hydrochloride (Cystanin) on host defense mechanism (IV): Potentiating effects on the function of peritoneal or spleen macrophages. Hisadome M; Kimura Y; Ikegami K; Terasawa M Jpn J Pharmacol; 1988 Aug; 47(4):379-85. PubMed ID: 3054218 [TBL] [Abstract][Full Text] [Related]
16. Heterogenous populations of cytotoxic cells in the peritoneal cavity of BALB/c mice immunized with allogeneic EL4 leukemia cells. Zighelboim J; Bonavida B; Fahey JL Cell Immunol; 1974 May; 12(2):280-9. PubMed ID: 4458965 [No Abstract] [Full Text] [Related]
17. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity. Evans R; Alexander P Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104 [TBL] [Abstract][Full Text] [Related]
18. Role of macrophage activation in allograft immunity: in vivo studies. Debray-Sachs M; Dy M; Hamburger J Ann Immunol (Paris); 1979; 130C(5):721-33. PubMed ID: 393160 [TBL] [Abstract][Full Text] [Related]
19. A novel rat monoclonal antibody directed against a population of activated mouse peritoneal macrophages. Someya A Microbiol Immunol; 1986; 30(6):573-88. PubMed ID: 3747866 [TBL] [Abstract][Full Text] [Related]
20. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor. Evans R; Grant CK; Cox H; Steele K; Alexander P J Exp Med; 1972 Nov; 136(5):1318-22. PubMed ID: 4117192 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]